Table 2.

Association between GlycA, coronary artery disease and mortality, stratified by diabetes status.a

CADAll-cause mortality
Basic OR (CI)Adjusted OR (CI)bBasic HR (CI)Multivariable HR (CI)a
Full population1.14 (1.09–1.20), P <0.00011.07 (1.02–1.13), P = 0.0131.39 (1.34–1.44), P <0.00011.34 (1.29–1.39), P <0.0001
Diabetes1.01 (0.92–1.11), P = 0.0781.03 (0.93–1.14), P = 0.581.30 (1.24–1.37), P <0.00011.28 (1.21–1.36), P <0.0001
No diabetes1.14 (1.07–1.21), P <0.00011.09 (1.02–1.16), P = 0.0091.42 (1.36–1.48), P <0.00011.38 (1.32–1.45), P <0.0001
Cardiovascular mortalityc
1.37 (1.30–1.45) P <0.0001
Noncardiovascular mortality
1.47 (1.39–1.54) P <0.0001
Other mortality
1.23 (1.10–1.38) P <0.001
  • a HR per 1 SD increase in GlycA concentrations.

  • b Adjusted for age, sex, race, BMI, diabetes, hypertension, smoking, hyperlipidemia, and LDL-P, and additionally for presence of CAD and ejection fraction in mortality models.

  • c Multivariable model HR for CV mortality in the full population.